drugset / Trial / NCT04883619

A Study of Nipocalimab in Adult Participants With Active Lupus Nephritis

NCT04883619

RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to evaluate the efficacy of nipocalimab versus placebo in participants with active Lupus Nephritis (LN).

Timeline

Start
2026-01-15
Primary completion
2028-02-28
Completion
2028-02-28

Drugs

EvaluationDrugModalityDoseRoute
Subject Nipocalimab Monoclonal antibody Intravenous
Background Mycophenolate Mofetil Small molecule Intravenous
Background mycophenolic acid Small molecule Intravenous

Indications